Chronic Fatigue Syndrome in Adults (Pitta-dominant years, ~16-50)

About Chronic Fatigue Syndrome in Adults (Pitta-dominant years, ~16-50)

Post-exertional malaise is the cardinal feature that distinguishes ME/CFS from fatigue in general — symptoms worsen 24 to 72 hours after activity that was once tolerated, and the crash is reproducible. The IOM 2015 SEID framework requires at least six months of substantial functional reduction, unrefreshing sleep, PEM, and either cognitive impairment or orthostatic intolerance. Women carry roughly four times the prevalence; peak adult onset clusters in the 30s and 40s, often after a viral illness or under sustained physiological stress.

Long-COVID brought ME/CFS into mainstream recognition; current consensus places 30-50% of long-COVID cases inside the ME/CFS criteria. Severity runs from mild (functional but reduced) through moderate (housebound much of the week) to very-severe (bed-bound, dark room, tube-fed).

Ayurvedically the picture is ojakshaya with dhatu-kshaya progressing through rasa and rakta into deeper tissues, agni-mandya expressing as post-prandial collapse and food sensitivities, vata-prakopa atop a depleted substrate, and manovaha-srotas involvement driving the cognitive symptoms. Comorbid POTS, mast cell activation, small-fiber neuropathy, and reactivated EBV or other herpesviruses are common and worth identifying.

Pacing — the energy-envelope approach, heart-rate-guided for some — is the NICE 2021 recommended primary intervention. Graded exercise is now contraindicated per NICE 2021. Rasayana-tone treatment, classically sequenced and only in stable phases, is described in Charaka Rasayana Adhyaya as rebuilding ojas over years.

Significance

Adult-onset ME/CFS is the peak window for the syndrome, and the modern recognition driver has been long-COVID — 30 to 50% of post-acute SARS-CoV-2 cases meet ME/CFS criteria, finally bringing decades of patient testimony into clinical attention.

Post-exertional malaise as the cardinal feature distinguishes ME/CFS from deconditioning, depression, or general fatigue, and clarifies the treatment frame.

NICE 2021 reversed prior guidance and removed graded exercise therapy from recommendations; pacing took its place. Cognitive-behavioral approaches support coping but are not curative — framing them otherwise has caused real harm.

Doshically the midlife window sits under pitta dominance, but ME/CFS shifts the substrate toward vata-prakopa on a depleted ojas base, and treatment leans rasayana rather than shodhana until stability returns. Long-COVID-driven recognition has opened space for low-dose naltrexone trials, mast-cell workup, and POTS-aware care.

Connections

Adult ME/CFS overlaps clinically with fibromyalgia in midlife — central sensitization and pain co-travel with fatigue in many cases — and with depression in midlife and insomnia in midlife, though these are secondary to the exertion-intolerance core. Hypothyroidism should be ruled out before diagnosis is finalized. Constitutional vata reading clarifies the depleted-substrate picture, and rasayana therapy provides the ojakshaya-targeted treatment frame for stable-phase rebuilding.

Further Reading

• Charaka Samhita Chikitsa Sthana ch 1 Rasayana Adhyaya on rasayana therapy for ojakshaya; Sushruta Sutra ch 15 on dhatu-mala-vridhi-kshaya. IOM 2015 SEID criteria. NICE 2021 guideline NG206 — disavows graded exercise therapy and centers pacing. Davis et al 2023 Nature Reviews Microbiology on long-COVID and ME/CFS overlap. Emerging LDN literature for ME/CFS and long-COVID.